The Biden administration has announced the selection of 10 high-cost prescription drugs for price negotiations with pharma companies to help older and disabled Americans afford their medication. The controversial move is a step towards addressing Medicare's drug pricing issue. President Biden hailed […]
Healthcare Data Market Forecasted to Triple by 2030 Amidst Real-World Evidence Boom
The mass digitization of healthcare records has created a wealth of clinical data assets, leading to a predicted 14.6% growth in the market through 2030, increasing its value from $4.6 billion to $13.6 billion. This growth is catalyzed by trends, including the widespread adoption of electronic […]
Mallinckrodt Files for Second Bankruptcy; Plans $1 Billion Debt Reduction Amid Opioid Litigation
Drugmaker Mallinckrodt has filed for its second bankruptcy in the US within three years, with a restructuring plan aiming to alleviate $1 billion from its owed amount to victims of the opioid crisis. The firm began Chapter 11 proceedings following an agreement that would hand the company over to its […]
Medicare to Negotiate Prices for 10 High-Cost Drugs Under New Democratic Reform Law
Medicare will negotiate prices for ten high-cost drugs, including major diabetes medications and blood thinners, as part of a drug pricing reform law by Democrats. Here's what you need to know: The new prices will be announced in September 2024 and will take effect from January 2026. The […]
Medtronic’s Inceptiv System: A New Auto-Adjusting Spinal Cord Stimulator Receives EU Approval
Medtronic has developed a spinal cord stimulator called the Inceptiv system, which alleviates discomfort caused by movements shifting the position of standard systems. The system automatically adjusts to movements, removing the need for users to alter their therapy according to their actions. When […]
Danaher Acquires Life Sciences Supplier Abcam for $5.7 Billion
Danaher Corporation has announced the acquisition of Abcam, a UK-based life sciences supplier, for $5.7 billion. Abcam, a producer of research items such as antibodies and biomarkers, engaged in discussions with 20 other potential buyers before they decided to complete the acquisition with Danaher. […]
UK Economy Showing Signs of Growth Despite Skills Shortage and Employment Challenges in the Biosciences Industry
The UK economy appears to avoid a possible recession and even shows signs of growth, according to the latest data from the Office for National Statistics (ONS). However, concerns persist about a challenging employment scenario in the biosciences industry due to a digital and data skills shortage in […]
Aetion’s SURF Tool: Advancing Feasibility Assessment of Real-World Evidence in FDA Applications
Aetion®, a leader in real-world evidence (RWE) technology and analytics, has published 'SURF,' a tool intended to assist sponsors in assessing the feasibility of utilizing real-world data (RWD) to provide evidence supporting an effectiveness claim in a U.S. Food and Drug Administration (FDA) […]
Cellares Secures $255M in Series C Round of Funding
Cellares, a cell therapy manufacturer based in South San Francisco, announced a $255 million series C investment round to finish constructing its commercial-scale cell therapy manufacturing facility in Bridgewater, NJ. Koch Disruptive Technologies led the funding round and included pharmaceutical […]
Atropos Health Expands into Life Sciences Sector
Atropos Health, acclaimed for its Green Button Clinical Informatics Consult Service, is expanding into the life sciences sector. It will utilize its Evidence Platform for various life sciences applications, including AI innovations and evidence generation. A Life Science Advisory Board is […]
Leo Pharma Acquires Timber Pharmaceuticals for $36M to Bolster Dermatology Pipeline
Leo Pharma has agreed to acquire US-based Timber Pharmaceuticals, a clinical-stage biopharma company that develops treatments for rare skin conditions, for $36 million. The deal mandates an initial payment of $14 million and commits to $22 million in further payments as future milestones are […]
Microsoft and Epic Expand Partnership: Generative AI Integration in Healthcare to Alleviate Workforce Burnout and Staff Shortages
Microsoft and Epic are extending their partnership to incorporate AI technologies in the healthcare sector. This joint venture aims to address critical issues, including workforce burnout and staff shortages. Key areas of collaboration include the employment of conversational, ambient, and […]
Target RWE to Showcase Innovative Epidemiology Research and Launch Syndicated Science™ Insights
Target RWE, a leader in real-world evidence, will present innovative research in epidemiology and statistics at the International Society for Pharmacoepidemiology's 39th annual meeting from August 23-27, 2023. The company's top executives will conduct a pre-conference skills course on 'Methods and […]
Boehringer Ingelheim Files Lawsuit Against U.S. Government Over Medicare’s Drug Price Negotiation Power
Boehringer Ingelheim has filed a lawsuit against the U.S. government, arguing that Medicare's new power to negotiate drug prices is unconstitutional and forces pharmaceutical companies to adhere to unfairly imposed terms. The company joins Merck & Co, Bristol Myers Squibb, Astellas Pharma, and […]
Bruker to Acquire PhenomeX for $108M
Bruker Corporation is actively acquiring PhenomeX in a cash deal valued at $108 million. PhenomeX, a product of Berkeley Lights' acquisition of IsoPlexis, performs analysis on live biological function. This acquisition will allow Bruker to enter into single-cell research, boosting its spatial […]
Advancements in Healthcare: The Influential Roles of Artificial Intelligence and Data Science
The last decade in healthcare has seen notable advancements due to artificial intelligence (AI), particularly data science. By using data-driven insights, healthcare decisions are more accurate and personalized. This article highlights five key healthcare data science projects: Google's […]
Preliminary Data Suggests Moderna’s Updated Covid-19 Vaccine Effective Against Expected Fall Variants
Moderna's preliminary data suggests that its updated COVID-19 vaccine can effectively combat expected variants this fall, including Eris and Fornax. This news comes amid a recent surge in COVID cases across the US. Moderna and Pfizer/BioNTech hope for FDA approval for their updated vaccines in time […]
Strategic Planning, Partnerships, and Compliance in Conflict Zones
Here's What You Need to Know: The PwC 25th Annual Global CEO Survey showed that geopolitical conflicts significantly threaten global growth, with 71% of CEOs saying they could inhibit business operations. Such conflicts can cause operating challenges for companies, particularly those […]
FDA Approves Ipsen’s Ultra-Rare Bone Disease Drug Sohonos
The Food and Drug Administration (FDA) has approved Ipsen Pharmaceuticals' Sohonos, a drug designed to treat fibrodysplasia ossificans progressiva (FOP), an ultra-rare bone disease. The drug reduces undesired bone formation in soft tissues and is slated for use in females over eight and males over […]
Japanese Government Funds Arcturus Therapeutics with $115M for mRNA Vaccine Production Expansion
San Diego's RNA biotech firm, Arcturus Therapeutics, has received a $115 million grant from the Japanese government for its manufacturing operations, Arcalis Co., Ltd. The joint venture between Arcturus and Tokyo-based company Axcelead will build a Minamisoma City factory to produce materials for […]
FDA to Decide on Bluebird Bio’s Gene Therapy for Sickle Cell Disease
Bluebird Bio's gene therapy for Sickle Cell Disease (SCD), lovotibeglogene autotemcel (lovo-cel), is awaiting FDA approval, with the decision expected by December 20. The FDA has opted not to hold an advisory committee meeting before the decision. Lovo-cel, backed by efficacy results from 36 […]
Federal Appeals Court Restricts Access to Abortion Pill Mifepristone
A federal appeals court has ruled to restrict access to the abortion pill mifepristone but has not removed it from the market entirely, upholding part of a lower court’s decision. The 5th U.S. Circuit Court of Appeals decision could prevent the pill from being distributed through mail-order […]
Updates to Keep an Eye on
The FDA has fast-tracked approval of Pfizer's Elfrexfio drug for hard-to-treat multiple myeloma, offering new hope to patients. State and local governments are currently wrestling with how best to distribute funding from opioid crisis-related settlements as public health groups question the […]
Genentech to Pay $158,208 for Environmental Violations
Genentech has agreed to pay a $158,208 fine to the U.S. Environmental Protection Agency (EPA) over environmental violations at its closed plant in South San Francisco. The violations discovered during a 2021 inspection include: Instances of improper disposal of hazardous materials. […]
Rising Biotech Stocks: Key Players to Monitor
10 Things You Need to Know: Biotech stocks continue to prosper long-term despite periodic fluctuations. In 2020, prominent biotech companies Pfizer and its partner BioNTech, Moderna, and Johnson & Johnson took the lead in launching COVID-19 vaccines. Investor's Business Daily's […]
Segmed Exceeds 100 Million Imaging Studies Milestone on Its Network
Segmed, a company that focuses on simplifying access to real-world medical imaging data (RWiD), has announced its network has surpassed 100 million imaging studies due to partnerships with national and international healthcare providers. The company facilitates the connection between healthcare […]
Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt their businesses as the focus shifts from pandemic to endemic status. Here's what you need to know: Many biopharma companies, including Pfizer, […]
Supreme Court Halts Purdue Pharma’s Bankruptcy Plan Worth Billions
The Supreme Court has ordered a temporary halt on the proposed bankruptcy plan for Purdue Pharma, which would distribute billions of dollars toward resolving the opioid crisis in the USA---Purdue Pharma has said that under the negotiated deal, the Sacklers would pay up to $6 billion over nearly two […]
Skepticism Surrounds NIH’s Long Covid Clinical Trials
The National Institutes of Health (NIH) initiated clinical trials for long Covid – persistent symptoms following a COVID-19 infection – two years post receiving $1.15 billion from Congress for research and treatment. Yet, the outlook is met with skepticism from scientists and patients alike, raising […]
Act4Biosimilars Advocacy Group Strives to Boost Global Adoption of Biosimilars by 2030
Act4Biosimilars, a global biosimilar advocacy initiative, aims to increase global adoption of biosimilars by at least 30 percentage points in over 30 countries by 2030. Here's what you need to know: Regulatory and policy hurdles and varied market dynamics cause disparities in biosimilar […]
